Page 2 - Urinary Bladder News Today

According to the IARC, there are four different levels of classifications - carcinogenic, probably carcinogenic, possibly carcinogenic and not classifiable. The levels are based on the strength of the evidence, rather than how dangerous a substance is. Here is a look at some of the top agents that are carcinogenic to humans based on their classifications: CATEGORY-1: WHEN AN AGENT IS CONSIDERED 'CARCINOGENIC TO HUMANS' As per IARC, this classification is used when there is enough proof...

Bladder diverticula are outward bulges of the inner (epithelial) lining of the urinary bladder through a defect in its muscle layer. They may be present since birth or acquired later in life. Most of them do not need any treatment unless they are causing problems

Bladder cancer occurs due to abnormal cell growth in the urinary bladder. The most common kind usually is urothelial cancer or ​transitional cell carcinoma.

Lawyers for a man who alleges he developed bladder cancer after taking heartburn drug Zantac urged a California judge on Thursday to allow expert testimony at an upcoming trial.

This case brought to notice a very rare consequence of shingles infection.

Urinary Catheters Market Expansion to be Persistent by 2028

Urinary Catheters Market Expansion to be Persistent by 2028

Doctors have performed a challenging operation in a young patient, who had a history of a stone in left ureter, the pipe connecting kidney and urinary bladder.

Urinary incontinence in female athletes linked to low energy availability: Study Athletes train a variety of muscle groups, such as back, chest, arms, legs and abs. But one area often overlooked is the pelvic floor. Urinary incontinence affects women of all ages and athletic abilities, but is often underreported. Those participating in high impact sports reported the highest prevalence of urinary incontinence. Previous studies have shown that female athletes who expe...

Read more about Immunotherapy after bladder cancer surgery may reduce recurrence: Study on Business Standard. Researchers at the Memorial Sloan Kettering Cancer Center found that patients who received nivolumab after bladder cancer surgery reduced their overall risk for high-grade bladder cancer recurrence